Try our Advanced Search for more refined results

Apotex Corp. v. Hospira Healthcare India Private Limited

  1. February 20, 2020

    Apotex Suit Against Pfizer Unit Teed Up For State Court

    Apotex Corp. will get another chance to show that Hospira Inc. reneged on the pair's exclusive drug supply agreement and instead formed a monopoly, as the New York federal judge who recently axed the bulk of Apotex's allegations decided a state court should hear the remaining claims.

  2. January 06, 2020

    Pfizer Unit's Alleged Drug Supply Cuts Aren't Anticompetitive

    A New York federal judge on Monday tossed Apotex Corp.'s antitrust claims alleging that Pfizer subsidiary Hospira Inc. broke their exclusive agreement and cut off its supply for the generic antibiotic cefepime to form a monopoly, finding that the subsidiary never held market power and that the claims are merely a "re-casting" of state contract claims.

  3. June 04, 2018

    Pfizer Unit Used Partnership To Cut Rival's Supply, Suit Says

    Apotex Corp. hit Pfizer subsidiary Hospira Inc. with a suit Friday in New York federal court alleging it reneged on a noncompete agreement to supply Apotex with generic antibiotics Apotex helped develop, causing Apotex to flounder in the U.S. drug market and lose out on hundreds of millions of dollars in profits.